Balloon-occluded hepatic arterial infusion for unresectable hepatocellular carcinoma: a phase II trial interim analysis - Scorecard - MDSpire

Login

Balloon-occluded hepatic arterial infusion for unresectable hepatocellular carcinoma: a phase II trial interim analysis

By
Feng Li
Jian Zhang
Xiangbo An
Jianfei Liu
Benkei Li
Haiwei Li
Li Jun
Ningfang Wang
Guinan Jiang
Ye Jiang
Dehui Zhang
Fei Gao
Lei Song
Jun Zhou
Wenheng Zheng
Min Ji
Feng Wang
June 1, 2026
0 min

Frontiers In Oncology

Share

Clinical Scorecard: Interim Analysis of a Phase II Study on Balloon-Occluded Hepatic Arterial Infusion for Patients with Unresectable Hepatocellular Carcinoma

At a Glance

Category	Detail
Condition
Key Mechanisms	Remove unsupported claim; ensure it is directly sourced.
Target Population
Care Setting

Key Highlights

remove

Guideline-Based Recommendations

Diagnosis

Management

E
n
s
u
r
e
a
l
l
m
a
n
a
g
e
m
e
n
t
p
r
a
c
t
i
c
e
s
a
r
e
d
i
r
e
c
t
l
y
s
u
p
p
o
r
t
e
d
.

Monitoring & Follow-up

Risks

Patient & Prescribing Data

Remove unsupported phrase.

Clinical Best Practices

remove

Related Resources & Content

Clinical Trial Registration

Original Source(s)

Frontiers In Oncology

Balloon-occluded hepatic arterial infusion for unresectable hepatocellular carcinoma: a phase II trial interim analysis

by Feng Li, Jian Zhang, Xiangbo An, Jianfei Liu, Benkei Li, Haiwei Li, Li Jun, Ningfang Wang, Guinan Jiang, Ye Jiang, Dehui Zhang, Fei Gao, Lei Song, Jun Zhou, Wenheng Zheng, Min Ji, Feng Wang
June 1, 2026

Related Content

The Medicine Maker

This Week’s CGT News: Base Editing Takes Aim at Cholesterol

Verve reports phase 1 data for one-time PCSK9 base editing; plus: neuroprotective gene therapy, non-viral DNA delivery, tumour-activated CAR-T, and in vivo CAR-M